India exports a large amount of Pharmaceuticals to more than 200 countries around the world. The current worth of the pharmaceutical sector in India is $50 billion. India meets more than half of Africa's generic drug needs, 40% of generic drug...
The pharmaceutical analytical testing market is experiencing substantial expansion due to increased complexity in drug development and growing need for biologics and biosimilars, as per the report by Straits Research Pvt. Ltd...
Lupin has one of the quickest increases in the S&P Global ESG scores among pharmaceutical companies in India. Lupin Limited, a leading pharmaceutical company, reported an increase in its S&P Global ESG scores from 69 to 76, surpassing the industry...
India's healthcare system favors curative care, with 38% of spending going towards in-patient services and treatments, compared to just 14% for preventative care. Healthcare costs are also rising, with claim sizes up 11.4% and medical inflation at...
The country's top pharmaceutical companies experienced a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, mainly due to their strong performance in North America and the domestic market, as per Axis Securities report...
Indian pharmaceutical firms have pledged to invest more than Rs 5,260 crore, with the goal of generating 12,490 job openings within the pharmaceutical industry. The Telangana government has announced that six well-known pharmaceutical companies...
Researcher and CEO of Arc Fusion, David Ewing Duncan, while speaking at Bengaluru Tech Summit 2024, talked about the idea of super convergence where technologies like AI, genomics, and synthetic biology are coming together to change health and hum...
The Indian pharmaceutical industry, known as the ‘pharmacy of the world’, has faced a trend of negative net voluntary licensing and technology transfers – constructive for medicine access in LMICs, according to the 2024 Access to Medicine Index. Rele
The rapid advancements in quality control techniques and testing methods have been driven by the rising need for safe, effective medications of high quality. The market is growing due to increased attention on product quality and adherence to...
Anti-diabetics and cardiac treatments are the main drivers of the domestic pharmaceutical market, with respiratory treatments projected to be the primary growth drivers in November, December, and January. With air pollution persisting, it is...
, CDSCO.jpg)
